Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

More on anti-HIV research at Glaxo Wellcome

March 4, 1998

No Comments

ArQule and Sepracor to optimize lead antiinfective compounds

March 4, 1998

No Comments

Additional phase I/II data reported for Panretin Gel in KS

March 3, 1998

No Comments

Cyclopropane analogues as potent anti-HIV-1 agents

Feb. 26, 1998

No Comments

Agouron discloses new HIV protease inhibitors

Feb. 26, 1998

No Comments

Tripos and Sepracor to collaborate on discovery of HIV protease inhibitors

Feb. 26, 1998

No Comments

Alferon N Injection for HIV-infected patients makes progress

Feb. 26, 1998

No Comments

Nucleoside with potent and selective anti-HIV and anti-HBV activity

Feb. 25, 1998

No Comments

Quinolone HIV integrase inhibitors prepared at Warner-Lambert

Feb. 24, 1998

No Comments

Controlled trial of peptide T for cognitive impairment in HIV-infected patients

Feb. 23, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

HIV/AIDS
RSS

More on anti-HIV research at Glaxo Wellcome

ArQule and Sepracor to optimize lead antiinfective compounds

Additional phase I/II data reported for Panretin Gel in KS

Cyclopropane analogues as potent anti-HIV-1 agents

Agouron discloses new HIV protease inhibitors

Tripos and Sepracor to collaborate on discovery of HIV protease inhibitors

Alferon N Injection for HIV-infected patients makes progress

Nucleoside with potent and selective anti-HIV and anti-HBV activity

Quinolone HIV integrase inhibitors prepared at Warner-Lambert

Controlled trial of peptide T for cognitive impairment in HIV-infected patients

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

HIV/AIDS RSS

HIV/AIDS
RSS